CNBC September 20, 2023
Stefan Sykes

Key Points

– Tobacco giant Philip Morris International is considering selling off a stake in its largest pharmaceuticals unit.

– The company has been making inroads into the wellness and health-care space in recent years as it pivots toward becoming a business focused on smoke-free products and respiratory medicines.

– More recently, the division has struggled, and Philip Morris has had talks with Deutsche Bank on a range of options to try to grow its wellness and health-care division.

Philip Morris International is considering selling off a stake in its largest pharmaceuticals unit.

The tobacco company, which makes Marlboro cigarettes, made inroads into the health care and wellness space in 2021 with the acquisition of Vectura, a U.K.-based pharmaceutical company...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Provider, Trends, Wellness
Gen X Less Interested in Trendy Wellness, More Stressed Than Boomers
American Medical Association suggests realistic health goals in 2025
Study: Why Quick Fixes Don’t Work in Workplace Wellness
Will the Trump Administration Be a Dangerous Ally to the Wellness Industry?
B2B Wearables: A New Tool for Businesses to Promote Workplace Wellness

Share This Article